JPWO2021202678A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021202678A5 JPWO2021202678A5 JP2022560206A JP2022560206A JPWO2021202678A5 JP WO2021202678 A5 JPWO2021202678 A5 JP WO2021202678A5 JP 2022560206 A JP2022560206 A JP 2022560206A JP 2022560206 A JP2022560206 A JP 2022560206A JP WO2021202678 A5 JPWO2021202678 A5 JP WO2021202678A5
- Authority
- JP
- Japan
- Prior art keywords
- cytokine
- masked
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025186059A JP2026048631A (ja) | 2020-04-01 | 2025-11-05 | マスクされたｉｌ－１２サイトカイン及びその切断産物 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003842P | 2020-04-01 | 2020-04-01 | |
| US63/003,842 | 2020-04-01 | ||
| US202063118579P | 2020-11-25 | 2020-11-25 | |
| US63/118,579 | 2020-11-25 | ||
| US202063127893P | 2020-12-18 | 2020-12-18 | |
| US63/127,893 | 2020-12-18 | ||
| PCT/US2021/025107 WO2021202678A1 (en) | 2020-04-01 | 2021-03-31 | Masked il-12 cytokines and their cleavage products |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025186059A Division JP2026048631A (ja) | 2020-04-01 | 2025-11-05 | マスクされたｉｌ－１２サイトカイン及びその切断産物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023520518A JP2023520518A (ja) | 2023-05-17 |
| JPWO2021202678A5 true JPWO2021202678A5 (https=) | 2024-04-10 |
| JP2023520518A5 JP2023520518A5 (https=) | 2024-04-10 |
| JP7771076B2 JP7771076B2 (ja) | 2025-11-17 |
Family
ID=77929928
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560206A Active JP7771076B2 (ja) | 2020-04-01 | 2021-03-31 | マスクされたｉｌ－１２サイトカイン及びその切断産物 |
| JP2025186059A Pending JP2026048631A (ja) | 2020-04-01 | 2025-11-05 | マスクされたｉｌ－１２サイトカイン及びその切断産物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025186059A Pending JP2026048631A (ja) | 2020-04-01 | 2025-11-05 | マスクされたｉｌ－１２サイトカイン及びその切断産物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230159603A1 (https=) |
| EP (1) | EP4126249A4 (https=) |
| JP (2) | JP7771076B2 (https=) |
| KR (1) | KR20220161405A (https=) |
| CN (1) | CN115734806A (https=) |
| AU (1) | AU2021248919A1 (https=) |
| BR (1) | BR112022019708A2 (https=) |
| CA (1) | CA3172641A1 (https=) |
| IL (1) | IL296913A (https=) |
| MX (1) | MX2022012312A (https=) |
| PH (1) | PH12022552632A1 (https=) |
| TW (1) | TWI906278B (https=) |
| WO (1) | WO2021202678A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111630062A (zh) | 2017-11-28 | 2020-09-04 | 中外制药株式会社 | 具有可调节的配体结合活性的配体结合分子 |
| CA3100005A1 (en) | 2018-05-14 | 2019-11-21 | Werewolf Therapeutics, Inc. | Activatable cytokine polypeptides and methods of use thereof |
| AU2019271148B9 (en) | 2018-05-14 | 2025-05-29 | Werewolf Therapeutics, Inc. | Activatable interleukin-2 polypeptides and methods of use thereof |
| CN120463822A (zh) | 2018-09-27 | 2025-08-12 | 西里欧发展公司 | 掩蔽型细胞因子多肽 |
| KR20220023988A (ko) | 2019-05-14 | 2022-03-03 | 웨어울프 세라퓨틱스, 인크. | 분리 모이어티 및 이의 사용 방법 |
| BR112022009110A2 (pt) | 2019-11-14 | 2022-07-26 | Werewolf Therapeutics Inc | Polipeptídeos de citocina ativáveis e métodos de uso destes |
| AU2021254283B2 (en) | 2020-04-10 | 2025-12-11 | Cytomx Therapeutics, Inc. | Activatable cytokine constructs and related compositions and methods |
| WO2022115865A2 (en) * | 2020-11-25 | 2022-06-02 | Xilio Development, Inc. | Tumor-specific cleavable linkers |
| JP2024511387A (ja) * | 2021-03-16 | 2024-03-13 | シートムエックス セラピューティクス，インコーポレイテッド | マスクした活性化可能サイトカイン構成体ならびに関連する組成物及び方法 |
| TW202321282A (zh) | 2021-07-19 | 2023-06-01 | 美商再生元醫藥公司 | Il12受體促效劑及其使用方法 |
| WO2023161853A1 (en) | 2022-02-23 | 2023-08-31 | Bright Peak Therapeutics Ag | Activatable il-18 polypeptides |
| MX2024010488A (es) * | 2022-02-28 | 2024-09-05 | Xilio Dev Inc | Citocinas dirigidas y metodos de uso de estas. |
| WO2023220501A1 (en) * | 2022-05-12 | 2023-11-16 | Massachusetts Institute Of Technology | Activatable therapeutic peptides and uses thereof |
| US20260035434A1 (en) * | 2022-08-01 | 2026-02-05 | Ose Immunotherapeutics | Heterodimeric fc-clec-1 fusion molecule and uses thereof |
| CN117917438A (zh) * | 2022-10-21 | 2024-04-23 | 北京诺诚健华医药科技有限公司 | 抗体融合蛋白及其制备和应用 |
| US20240417436A1 (en) | 2023-01-11 | 2024-12-19 | Bright Peak Therapeutics Ag | Conditionally activated immunocytokines and methods of use |
| WO2024150175A1 (en) | 2023-01-11 | 2024-07-18 | Bright Peak Therapeutics Ag | Conditionally activated proteins and methods of use |
| CR20250279A (es) * | 2023-01-20 | 2025-08-25 | Boehringer Ingelheim Int | Proteínas de fusión fc de il-12 |
| EP4695281A1 (en) * | 2023-04-12 | 2026-02-18 | CytomX Therapeutics, Inc. | Masking polypeptides, activatable cytokine constructs, and related compositions and methods |
| WO2024216146A1 (en) * | 2023-04-12 | 2024-10-17 | Cytomx Therapeutics, Inc. | Masking polypeptides, activatable cytokine constructs, and related compositions and methods |
| CN121263432A (zh) * | 2023-04-12 | 2026-01-02 | 上海康抗生物技术有限公司 | 包含掩蔽型白介素12的多功能分子及使用方法 |
| WO2025041101A1 (en) | 2023-08-23 | 2025-02-27 | Bright Peak Therapeutics Ag | Activatable il-18 immunocytokines and uses thereof |
| WO2025119304A1 (en) * | 2023-12-07 | 2025-06-12 | Wuxi Biologics (Shanghai) Co., Ltd. | Heterodimeric proteins against il-12 receptor |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1489100B1 (en) * | 1997-12-08 | 2016-06-15 | Merck Patent GmbH | Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| BRPI0620648B1 (pt) * | 2005-12-30 | 2022-12-20 | Merck Patent Gesellschaft Mit Beschrãnkter Haftung | Variante de il-12 p40, proteínas il-12, il-23 e de fusão, composição farmacêutica e uso da mesma |
| AU2013381970A1 (en) * | 2013-03-15 | 2015-10-22 | Carnegie Mellon University | Linked peptide fluorogenic biosensors |
| MA41374A (fr) * | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci |
| CN108112254B (zh) * | 2015-03-13 | 2022-01-28 | 西托姆克斯治疗公司 | 抗-pdl1抗体、可活化的抗-pdl1抗体、及其使用方法 |
| JP7358047B2 (ja) * | 2016-05-16 | 2023-10-10 | チェックマブ エス．アール．エル． | 腫瘍浸潤制御性ｔ細胞において選択的に脱制御されたマーカー |
| MX2019004775A (es) * | 2016-11-03 | 2019-08-05 | Squibb Bristol Myers Co | Anticuerpos anti antigeno 4 del linfocito t citotoxico (ctla-4) activables y sus usos. |
| CN111527109B (zh) * | 2017-12-26 | 2024-11-01 | 南京金斯瑞生物科技有限公司 | 以抗体Fc区为骨架的融合蛋白二聚体及其应用 |
| CN108218993B (zh) * | 2018-01-05 | 2020-11-17 | 阿思科力(苏州)生物科技有限公司 | 一种以robo1为靶点的双特异性抗体及其制备和应用 |
| WO2019173832A2 (en) * | 2018-03-09 | 2019-09-12 | AskGene Pharma, Inc. | Novel cytokine prodrugs |
| CN110396133B (zh) | 2018-04-25 | 2021-07-23 | 免疫靶向有限公司 | 一种以白介素12为活性成分的融合蛋白型药物前体 |
| CA3100005A1 (en) * | 2018-05-14 | 2019-11-21 | Werewolf Therapeutics, Inc. | Activatable cytokine polypeptides and methods of use thereof |
| EP3810624A4 (en) * | 2018-06-22 | 2022-07-06 | Cugene Inc. | Cytokine-based bioactivatable drugs and methods of uses thereof |
| US12459980B2 (en) * | 2018-07-25 | 2025-11-04 | AskGene Pharma, Inc. | IL-21 prodrugs and methods of use thereof |
| CN120463822A (zh) * | 2018-09-27 | 2025-08-12 | 西里欧发展公司 | 掩蔽型细胞因子多肽 |
| EP3861016A2 (en) * | 2018-10-03 | 2021-08-11 | Xencor, Inc. | Il-12 heterodimeric fc-fusion proteins |
| US20220356221A1 (en) * | 2019-09-28 | 2022-11-10 | AskGene Pharma, Inc. | Cytokine prodrugs and dual-prodrugs |
| KR20260017503A (ko) * | 2020-02-14 | 2026-02-05 | 길리애드 사이언시즈, 인코포레이티드 | Ccr8에 결합하는 항체 및 융합 단백질, 및 이의 용도 |
| JP7773991B2 (ja) | 2020-03-23 | 2025-11-20 | ザイムワークス ビーシー インコーポレイテッド | マスクされたｉｌ１２融合タンパク質及びその使用方法 |
-
2021
- 2021-03-31 AU AU2021248919A patent/AU2021248919A1/en active Pending
- 2021-03-31 US US17/995,162 patent/US20230159603A1/en active Pending
- 2021-03-31 WO PCT/US2021/025107 patent/WO2021202678A1/en not_active Ceased
- 2021-03-31 JP JP2022560206A patent/JP7771076B2/ja active Active
- 2021-03-31 CA CA3172641A patent/CA3172641A1/en active Pending
- 2021-03-31 MX MX2022012312A patent/MX2022012312A/es unknown
- 2021-03-31 TW TW110112013A patent/TWI906278B/zh active
- 2021-03-31 KR KR1020227037411A patent/KR20220161405A/ko active Pending
- 2021-03-31 IL IL296913A patent/IL296913A/en unknown
- 2021-03-31 BR BR112022019708A patent/BR112022019708A2/pt unknown
- 2021-03-31 EP EP21781122.3A patent/EP4126249A4/en active Pending
- 2021-03-31 CN CN202180038975.1A patent/CN115734806A/zh active Pending
- 2021-03-31 PH PH1/2022/552632A patent/PH12022552632A1/en unknown
-
2025
- 2025-11-05 JP JP2025186059A patent/JP2026048631A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021202678A5 (https=) | ||
| US5763733A (en) | Antigen-binding fusion proteins | |
| JPWO2021207669A5 (https=) | ||
| JP2021521822A5 (https=) | ||
| RU2142015C1 (ru) | Фрагмент днк, кодирующий белок гелонина, и способ его получения, вектор, обеспечивающий экспрессию белка гелонина, рекомбинантный штамм e.coli - продуцент белка гелонина | |
| JP2020508691A5 (https=) | ||
| RU2011138951A (ru) | Пропротеины и способы их применения | |
| JPWO2021202675A5 (https=) | ||
| CA2331641A1 (en) | Multivalent antibody constructs | |
| JPWO2019204655A5 (https=) | ||
| CN113646328A (zh) | 一种免疫细胞因子及其制备与用途 | |
| JPH06239896A (ja) | 混成タンパク質 | |
| IE59488B1 (en) | Eukaryotic fusion proteins, the preparation and use there of, and means for carrying out the process | |
| JP2007519611A (ja) | 分泌された三量体受容体類似体及び生物学的活性融合タンパク質を製造するための方法及び組成物 | |
| ES2241040T3 (es) | Proteinas hibridas que forman heterodimeros. | |
| DE69233804D1 (de) | Nukleotidsequenzen, die für die veränderlichen Bereiche der Alpha-Ketten menschlicher T-Zell-Rezeptoren kodieren sowie ihre Verwendungen | |
| JPWO2019209965A5 (https=) | ||
| GB2172890A (en) | Epidermal growth factor production | |
| KR970070198A (ko) | 항-파스 재조합 항체 및 이에 대한 디엔아이 | |
| CN1055952A (zh) | 用链霉菌制备外源蛋白的方法 | |
| JP2636864B2 (ja) | 免疫グロブリンｅに対するポリペプチド競争体 | |
| WO2022129313A1 (en) | Precursor proteins and kit for targeted therapy | |
| Barthelemy et al. | Production and secretion of human interleukin 6 into the periplasm of Escherichia coli: efficient processing of N-terminal variants of hIL6 by the E. coli signal peptidase | |
| AU7526196A (en) | Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands | |
| JPWO2022197764A5 (https=) |